OrthoSystems Inc, formerly known as Advanced Resonance Technologies Inc and spun out of technology developed at Syracuse University, is a biotechnology company developing switch technology capable of a) creating rapid diagnostic tools for detection of chemical and biological targets, and b) leveraging this diagnostic platform for drug discovery applications. OrthoSwitch, OrthoSystems' platform technology, has demonstrated the ability of transducing molecular recognition of biological targets into a real-time (seconds) optical signal for identifying environmental and terrorist released contaminants in liquid systems. OrthoSwitch solutions are built on patent-pending biotechnology based on years of leading-edge biological research and industry partnerships at Syracuse University
